Does a negative sleep test mean you are in the clear? A full breakdown of the four kinds of test, the six situations that call for PSG, and the charges

TL;DR There is not one sleep apnoea test but at least four kinds: polysomnography (PSG) in a hospital or sleep centre, a home sleep apnoea test (HSAT) arranged after a doctor's assessment, screening devices (a ring or oximetry), and commercial packages. Their purposes and reliability differ, so you cannot compare them on the headline price alone. Published examples: Canossa Hospital diagnostic tests, out-patient HK$5,500–6,700 and in-ward HK$11,000 (general) / $12,500 (semi-private) / $13,600 (private); CUHK Medical Centre ring-based screening programme HK$1,750. And the thing readers most often miss: one negative in-facility PSG does not amount to ruling the diagnosis out. Which test suits you is for a doctor to decide.

#What is sleep apnoea, and why is loud snoring not just noise?

Obstructive sleep apnoea is not simply "sleeping badly" — it is a condition in which the airway repeatedly collapses during sleep and breathing stops again and again.

The Medical Device Division of the Department of Health describes it in its booklet this way: during sleep the muscles of the patient's upper airway relax excessively and obstruct the airway, causing brief pauses in breathing, and the patient wakes because the blood oxygen level falls; these brief apnoeas recur dozens or even hundreds of times through the night, greatly affecting sleep quality and leaving the patient sleepy during the day. [Note 1] The same booklet cites a survey: about 4% of middle-aged men and 2% of middle-aged women in Hong Kong have the condition.

Loud snoring is not only noise — it may be a symptom. The American Academy of Sleep Medicine (AASM) patient-education material states that snoring is the most common symptom of sleep apnoea, but not everyone who snores has it; what most likely signals it is snoring followed by silent breathing pauses and choking or gasping sounds. [Note 2]

The point is not whether the snoring is loud but whether the breathing stops. That clue has a practical limit, though: someone who sleeps alone, with nobody beside them to hear it, has no way of knowing whether they have pauses or choking sounds at all. The same AASM material lists other symptoms that stand on their own, without needing anyone to confirm a pause: daytime sleepiness or fatigue, and waking unrefreshed as though you had not slept. Anyone with those symptoms, or whose family or partner has noticed pauses, should see a doctor.

On risk factors, the AASM material gives the main one as being overweight — a body mass index (BMI) of 25 or above carries higher risk; others include a larger neck circumference (17 inches or more in men, 16 inches or more in women), middle age, male sex, high blood pressure, structural abnormalities of the airway (such as a deviated nasal septum or nasal polyps), family history, and the sedative effects of medication or alcohol. The material also stresses that people of slim build can have it too.

How bad can it get if it is left alone? The Department of Health booklet states that without appropriate treatment the load on the heart and lungs increases, raising the risk of complications such as high blood pressure, heart disease and stroke. [Note 1] The health effects listed in the AASM patient-education material include high blood pressure, heart disease, stroke, prediabetes and diabetes, and depression; the AASM diagnostic guideline (Kapur et al., 2017) further notes that untreated patients are associated with higher rates of job-related and motor vehicle accidents. [Note 3] These are risks recorded in the literature as associations — not a statement that every patient will experience them — but precisely because the consequences can be serious, both sources reach the same conclusion: anyone who suspects they have it should consult a doctor.

Who most needs to know this: people whose family complain that their snoring can be heard through the wall, and who often wake feeling as though they had not slept. Those two things are already reason enough to see a doctor, without waiting to confirm that there are pauses and choking sounds. Anyone living or sleeping alone, with nobody to notice whether the breathing stops, should be even less inclined to rely on that clue alone.

#What are the four kinds of sleep apnoea test?

Their purposes and reliability differ, and they should not be put on one price list without explanation.

Canossa also offers a CPAP titration study (in-ward: general $9,000 / semi-private $10,500 / private $11,600). Ring-based screening (③) and the diagnostic PSG / HSAT (① ②) serve different purposes; do not treat the cheaper one as equivalent. Whether a charge includes the device, the doctor's assessment, the technician, the report and follow-up must be confirmed item by item.

#What does each kind of test actually involve?

In-facility polysomnography (PSG): a night in a dedicated room at a hospital or sleep centre. Taking the test published by Canossa Hospital as the example, several groups of signals are recorded at once: electroencephalogram (EEG), electrocardiogram (ECG), electromyogram (EMG), electro-oculogram (EOG), snoring sounds, sleeping position, oral and nasal airflow, limb movement, blood oxygen saturation, and thoracic and abdominal respiratory effort. In other words, you sleep while multiple body-worn sensors record sleep stages, respiratory events and changes in blood oxygen — the more comprehensive diagnostic test. The next day you go home, and the data goes to a doctor to read.

Home sleep apnoea testing (HSAT): after a doctor's assessment, you take a portable device home and sleep a night in your own bed. It has fewer sensor channels than in-facility PSG, which is why the AASM guideline places it with clinically assessed adults without complex comorbidity in whom moderate to severe obstructive sleep apnoea is suspected. If the result is negative, inconclusive or technically inadequate, the guideline recommends moving to PSG in every case — and that recommendation does not depend on whether clinical suspicion remains.

Screening devices (ring or oximetry): preliminary screening only, not diagnosis. The CUHK Medical Centre ring-based programme, for instance, includes a pre-test assessment and analysis of the results. Where screening flags a risk, the next step is still a diagnostic test arranged by a doctor.

Who most needs to know this: people who snore loudly, are sleepy during the day, and want to "get some idea first". Screening devices have a low threshold — but if a doctor already suspects moderate to severe disease clinically, going straight to a diagnostic test may save a step.

#PSG or a home test?

This is a trade-off between convenience and comprehensiveness, and it should be assessed by a doctor according to clinical need. HSAT means sleeping at home with fewer channels; in-facility PSG means a night away but a more comprehensive record — though comprehensive does not mean one night is necessarily conclusive, which is what the rest of this section is about.

According to the AASM clinical practice guideline for the diagnosis of obstructive sleep apnoea in adults (Kapur et al., 2017), HSAT applies to clinically assessed adults without complex comorbidity in whom moderate to severe obstructive sleep apnoea is suspected. The guideline sets out six situations in which it recommends PSG directly rather than HSAT: significant cardiorespiratory disease, respiratory muscle weakness due to a neuromuscular condition, awake hypoventilation or suspected sleep-related hypoventilation, chronic opioid use, a history of stroke, or severe insomnia.

And if a single HSAT is negative, inconclusive or technically inadequate, the guideline recommends moving to PSG in every case. That is an unconditional recommendation: it does not depend on whether clinical suspicion remains. In other words, HSAT is convenient but does not suit everyone, and "negative" does not necessarily mean "nothing there" — which is exactly where the trade-off lies.

That reminder applies to in-facility PSG too, not only to HSAT. The guideline carries a further recommendation: where a first in-facility PSG is negative but clinical suspicion remains, a second PSG may be considered. The evidence it cites is a pooled analysis of four studies, graded "high": between 9.9% and 25% of those tested had an apnoea-hypopnoea index (AHI) below 5 on the first night of PSG — a negative result — but rose to 5 or above on the second night, turning positive. [Note 4]

So one negative in-facility PSG cannot be treated as ruling the diagnosis out either. This article reports the guideline and does not recommend a type of test for any individual case; anyone who suspects sleep apnoea (interrupted snoring, extreme daytime sleepiness) should seek care first and let a sleep or respiratory physician judge.

Working the numbers (using published institutional charges): on the published examples, doing the CUHK Medical Centre ring-based screening first ($1,750) and then, if it flags a risk, the Canossa out-patient diagnostic test (from $5,500) comes to $7,250 and up — more than going straight to the out-patient diagnostic test at $5,500 and up. This calculation uses the published price of this one screening device: its value is the low threshold, which is not the same as saving money, and the conclusion reflects only this institution's published price, not every screening device on the market. Which route to take is for a doctor to decide, according to the degree of clinical suspicion.

Who most needs to know this: working adults without complex comorbidity in whom a doctor suspects moderate to severe disease — HSAT may be the convenient choice. For anyone with significant cardiorespiratory disease, neuromuscular respiratory muscle weakness, hypoventilation, chronic opioid use, a history of stroke or severe insomnia, the guideline recommends PSG directly.

#After diagnosis: what options will a doctor usually discuss?

Once obstructive sleep apnoea is diagnosed, the treatment plan is decided by a doctor according to the condition and the individual. The following are the options set out in international guidelines that a doctor will usually discuss.

• Positive airway pressure (CPAP / PAP) — the AASM clinical guideline (Patil et al., 2019) strongly recommends PAP over no treatment for adults with OSA and excessive sleepiness, and also recommends pairing the start of PAP with educational and behavioural intervention. [Note 5] CPAP requires a separate titration study; see the Canossa charges above.
• Oral appliances — the AASM/AADSM guideline (Ramar et al., 2015) recommends that, for adults intolerant of CPAP therapy or who prefer an alternative, sleep physicians may consider prescribing an oral appliance rather than no treatment. [Note 6]
• Surgical assessment — the AASM guideline (Kent et al., 2021) recommends that, for adults intolerant of or unwilling to accept PAP (the guideline stratifies by BMI), clinicians may discuss referral for sleep surgery or bariatric surgery assessment; where there is a marked structural abnormality of the upper airway, the guideline recommends trying PAP first before considering surgical referral.
• Lifestyle measures — the PAP guideline above places education and behavioural intervention as part of the treatment package; specific goals are set by a doctor for the individual.

Which one suits you is for a doctor to decide. This article only reports the framework of the guidelines and does not constitute treatment advice. Associated costs (device, follow-up) are charged separately by each institution and are worth asking about at the same time as booking.

Who most needs to know this: people newly diagnosed who are uneasy about wearing a device all night. The guidelines already anticipate that — oral appliances and surgical assessment are both listed options — and telling your doctor what worries you is the next step.

#What to do next

1. If you have symptoms, see a doctor; do not wait until you can "confirm the pauses" yourself. Daytime sleepiness and waking unrefreshed are reason enough on their own, and anyone who sleeps alone especially should not rely on whether pauses have been noticed.
2. Ask the doctor which kind of test is being recommended. The four kinds serve different purposes: the diagnostic ones are in-facility PSG and an HSAT arranged after assessment; rings and oximetry are screening.
3. If you fall into one of those six situations, the guideline recommends PSG directly. Significant cardiorespiratory disease, neuromuscular respiratory muscle weakness, hypoventilation, chronic opioid use, a history of stroke, severe insomnia — tell your doctor about this history without being asked.
4. Do not treat a negative as an all-clear. Where an HSAT is negative, inconclusive or technically inadequate, the guideline recommends moving to PSG; where a first in-facility PSG is negative but clinical suspicion remains, the guideline says a second may be considered.
5. When you ask the price, ask what is included, item by item. Whether the device, the doctor's assessment, the technician, the report and follow-up are covered differs between institutions, and comparing headline prices alone will mislead you.
6. After diagnosis, say what worries you. Beyond CPAP there are oral appliances and surgical assessment, all set out in the guidelines; device and follow-up costs are charged separately by each institution.

#Frequently asked questions

Roughly what does a sleep study cost?

It depends on the kind. Published examples include Canossa Hospital diagnostic tests at out-patient HK$5,500–6,700 and in-ward HK$11,000 (general) / $12,500 (semi-private) / $13,600 (private); and the CUHK Medical Centre ring-based screening programme at HK$1,750, which is for screening and is not diagnostic. Whether a charge includes the device, the doctor's assessment, the report and follow-up must be confirmed item by item with the institution.

Can cheap ring-based screening replace PSG?

It cannot be treated as equivalent. Rings and oximetry are for screening, not diagnosis; the diagnostic tests are PSG and a home sleep apnoea test (HSAT) arranged after a doctor's assessment.

Should I have PSG or a home test (HSAT)?

That is for a doctor to decide on the clinical picture. The AASM guideline places HSAT with clinically assessed adults without complex comorbidity in whom moderate to severe obstructive sleep apnoea is suspected; it sets out six situations in which PSG should be used directly (significant cardiorespiratory disease, neuromuscular respiratory muscle weakness, hypoventilation, chronic opioid use, a history of stroke, severe insomnia), as set out above. Where an HSAT is negative or inconclusive, the guideline recommends moving to PSG in every case, regardless of whether clinical suspicion remains; and where a first in-facility PSG is negative but suspicion remains, it says a second may be considered.

What happens after diagnosis?

Common follow-up includes CPAP treatment (which requires a separate titration study — Canossa's in-ward titration study is $9,000 / $10,500 / $11,600 depending on ward class), an oral appliance, or other management recommended by a doctor; device and follow-up costs are charged separately by each institution.

#Notes: the official wording

[Note 1] Medical Device Division, Department of Health, "Obstructive Sleep Apnoea and Continuous Positive Airway Pressure Device": during sleep the muscles of the patient's upper airway relax excessively and obstruct the airway, causing brief pauses in breathing (apnoea), and the patient wakes because the blood oxygen level falls; these brief apnoeas "recur dozens or even hundreds of times through the night". On complications the same booklet states that without appropriate treatment the load on the heart and lungs increases, raising the risk of complications such as high blood pressure, heart disease and stroke. (The booklet is published in Chinese; this article renders it in English.)

[Note 2] AASM patient-education material (in English; this material has no Chinese version): "Snoring is likely to be a sign of sleep apnea when it is followed by silent breathing pauses and choking or gasping sounds."

[Note 3] The AASM guideline for the diagnosis of OSA in adults (Kapur et al., 2017) describes untreated patients in terms of "higher rates of job-related and motor vehicle accidents".

[Note 4] The pooled analysis cited by the same 2017 guideline on repeat PSG: four studies, evidence graded "high", with between 9.9% and 25% of those tested having an AHI below 5 on the first night of PSG and rising to 5 or above on the second.

[Note 5] The strong recommendation in the AASM 2019 PAP guideline, in the original English: "We recommend that clinicians use PAP, compared to no therapy, to treat OSA in adults with excessive sleepiness."

[Note 6] The AASM/AADSM 2015 oral appliance guideline, in the original English: "…for adult patients with obstructive sleep apnea who are intolerant of CPAP therapy or prefer alternate therapy."

#What this article does not state

• Which test suits you. This article sets out the purposes and published charges of the four kinds; the choice is for a doctor to make according to the degree of clinical suspicion.
• The value of every screening device on the market. The worked calculation above uses one institution's published price, and the conclusion reflects only that institution.
• Item-by-item pricing for diagnostic HSAT. No publicly available, item-by-item comparable diagnostic HSAT pricing was found, so none is listed.
• Charges that could not be verified. Current sleep study charges at Tsuen Wan Adventist Hospital (only an expired 2023 leaflet was found), prices for the Gleneagles home testing programme (not published), and SleepKinwood's item-by-item prices and test type (only a starting price is published) are all left out.
• Treatment advice. This article reports only the framework of options set out in the guidelines; it does not recommend a treatment for any individual patient.
• The actual cost of devices and follow-up. These are charged separately by each institution, and this article does not estimate them.

#Sources

• Definition of the condition, causal mechanism (relaxation of the upper airway muscles), how often it recurs each night, risk of complications (high blood pressure, heart disease, stroke) and Hong Kong prevalence (4% of middle-aged men / 2% of middle-aged women): Medical Device Division, Department of Health, "Obstructive Sleep Apnoea and Continuous Positive Airway Pressure Device" (revised January 2020) https://www.mdd.gov.hk/filemanager/common/information-publication/CPAP_Chi.pdf, retrieved 2026-07-31.
• Where snoring sits as a symptom, risk factors (being overweight as the main one, neck circumference, age, airway structure and so on) and the list of health effects: AASM patient education, Obstructive Sleep Apnea (August 2020 version, physician-reviewed) https://sleepeducation.org/sleep-disorders/obstructive-sleep-apnea/, retrieved 2026-07-31.
• Canossa Hospital sleep study charges: https://www.canossahospital.org.hk/en/service/health_check_services/sleep_apnoea_study/fees_and_charges/, retrieved 2026-07-27.
• CUHK Medical Centre Sleep Health Programme (ring-based screening $1,750): https://www.cuhkmc.hk/health-programmes/other-programmes/sleep-health-programme, retrieved 2026-07-27.
• SleepKinwood home sleep test (from $480): https://www.sleepkinwood.com/en/home-sleep-test, retrieved 2026-07-27.
• Where HSAT and PSG apply, the six comorbidities or situations for which PSG is recommended directly, the unconditional recommendation to move to PSG where an HSAT is negative / inconclusive / technically inadequate, the option of repeating a first negative in-facility PSG where clinical suspicion remains (including the pooled-analysis figures for the difference between two nights of PSG), and the description of untreated patients being associated with job-related and motor vehicle accident rates: American Academy of Sleep Medicine (AASM) clinical practice guideline for the diagnosis of OSA in adults (Kapur et al., J Clin Sleep Med 2017; DOI 10.5664/jcsm.6506), retrieved 2026-07-31.
• PAP treatment recommendation and the educational and behavioural package: AASM clinical guideline (Patil et al., J Clin Sleep Med 2019; DOI 10.5664/jcsm.7640), retrieved 2026-07-31.
• Oral appliance recommendation: AASM/AADSM clinical guideline (Ramar et al., J Clin Sleep Med 2015; DOI 10.5664/jcsm.4858), retrieved 2026-07-31.
• Surgical assessment referral recommendation: AASM clinical guideline (Kent et al., J Clin Sleep Med 2021; PMID 34351848), retrieved 2026-07-31.
• What in-facility PSG records (EEG / ECG / EMG / EOG, airflow, blood oxygen and so on): Canossa Hospital sleep study service page (the service to which the fees page belongs, see above).

#Could not be verified (not listed)

• Current sleep study charges at Tsuen Wan Adventist Hospital (only an expired 2023 leaflet was found); prices for the Gleneagles home testing programme (not published); SleepKinwood's item-by-item prices and test type (only a starting price is published).

Status of this material: clinical content is quoted from official and academic sources, each cited where it appears; prices and eligibility are first-hand or official information.

#Further reading

• On this platform: Cognitive behavioural therapy for insomnia

This article was compiled by the editorial team from official and academic sources; all clinical content is sourced. It is health information, not medical advice.